Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double-blind Placebo-controlled Trial of Brensocatib (INS1007) in Patients With Severe COVID-19

NCT04817332 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.

NCT NCT04817332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04817332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double-blind Placebo-controlled Trial of Brensocatib (INS1007) in Patients With Severe COVID-19
Lead sponsor
University of Dundee
Phase
Phase 3
Overall status
Completed
Start date
June 5, 2020
Completion date
February 28, 2021
Enrollment
406 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

covid19